Loading…

Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors

Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular neuroscience 2020-07, Vol.14, p.174-174
Main Authors: Sami, Armin, Selzer, Michael E, Li, Shuxin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853
cites cdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853
container_end_page 174
container_issue
container_start_page 174
container_title Frontiers in cellular neuroscience
container_volume 14
creator Sami, Armin
Selzer, Michael E
Li, Shuxin
description Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.
doi_str_mv 10.3389/fncel.2020.00174
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1994916447cf4d11b80f8de760e64977</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1994916447cf4d11b80f8de760e64977</doaj_id><sourcerecordid>2419545042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</originalsourceid><addsrcrecordid>eNpdkU1vEzEQhlcIRD_gzglZ4sJlgz_G9vqCFLU0RKoEonC27LU362hjF3vT0H_PJilVy8kjzzuP7Hmq6h3BM8Ya9amLrR9mFFM8w5hIeFGdEiFozQmmL5_UJ9VZKWuMBRXQvK5OGJUECMen1Y-5uzMTpaAQ0dh7dBNW0QwhrtB3M_Y7c1_QZdrFMmZvNih1aDEEM9Q3rclo_idFtMhpN_ZoGftgw5hyeVO96sxQ_NuH87z6dfXl58XX-vrbYnkxv65bUHisiZVUcUYocGaFJ7a1nuIGJFBqHEw94R0IAdxZJ6FRHRXEGug4EMEazs6r5ZHrklnr2xw2Jt_rZII-XKS80iaPoR28JkqBIgJAth04QmyDu8Z5KbAXoKScWJ-PrNut3XjX-jhmMzyDPu_E0OtVutOSgZCCTYCPD4Ccfm99GfUmlEnOYKJP26IpUMkpa6Saoh_-i67TNk9L36eI4sAx0CmFj6k2p1Ky7x4fQ7Dey9cH-XovXx_kTyPvn37iceCfbfYXV3-pTw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419545042</pqid></control><display><type>article</type><title>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content (ProQuest)</source><creator>Sami, Armin ; Selzer, Michael E ; Li, Shuxin</creator><creatorcontrib>Sami, Armin ; Selzer, Michael E ; Li, Shuxin</creatorcontrib><description>Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.</description><identifier>ISSN: 1662-5102</identifier><identifier>EISSN: 1662-5102</identifier><identifier>DOI: 10.3389/fncel.2020.00174</identifier><identifier>PMID: 32714150</identifier><language>eng</language><publisher>Switzerland: Frontiers Research Foundation</publisher><subject>Antigens ; axon regeneration ; Cellular Neuroscience ; Chondroitin sulfate ; CSPG receptor ; Heparan sulfate ; Injuries ; intracellular signaling ; Intracellular signalling ; Kinases ; LAR ; Mammals ; Phosphatase ; Proteins ; Proteoglycans ; PTPσ ; Regeneration ; scar inhibition ; Signal transduction ; Spinal cord ; Spinal cord injuries ; Traumatic brain injury ; Tyrosine</subject><ispartof>Frontiers in cellular neuroscience, 2020-07, Vol.14, p.174-174</ispartof><rights>Copyright © 2020 Sami, Selzer and Li.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © 2020 Sami, Selzer and Li. 2020 Sami, Selzer and Li</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</citedby><cites>FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2419545042/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2419545042?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32714150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sami, Armin</creatorcontrib><creatorcontrib>Selzer, Michael E</creatorcontrib><creatorcontrib>Li, Shuxin</creatorcontrib><title>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</title><title>Frontiers in cellular neuroscience</title><addtitle>Front Cell Neurosci</addtitle><description>Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.</description><subject>Antigens</subject><subject>axon regeneration</subject><subject>Cellular Neuroscience</subject><subject>Chondroitin sulfate</subject><subject>CSPG receptor</subject><subject>Heparan sulfate</subject><subject>Injuries</subject><subject>intracellular signaling</subject><subject>Intracellular signalling</subject><subject>Kinases</subject><subject>LAR</subject><subject>Mammals</subject><subject>Phosphatase</subject><subject>Proteins</subject><subject>Proteoglycans</subject><subject>PTPσ</subject><subject>Regeneration</subject><subject>scar inhibition</subject><subject>Signal transduction</subject><subject>Spinal cord</subject><subject>Spinal cord injuries</subject><subject>Traumatic brain injury</subject><subject>Tyrosine</subject><issn>1662-5102</issn><issn>1662-5102</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkU1vEzEQhlcIRD_gzglZ4sJlgz_G9vqCFLU0RKoEonC27LU362hjF3vT0H_PJilVy8kjzzuP7Hmq6h3BM8Ya9amLrR9mFFM8w5hIeFGdEiFozQmmL5_UJ9VZKWuMBRXQvK5OGJUECMen1Y-5uzMTpaAQ0dh7dBNW0QwhrtB3M_Y7c1_QZdrFMmZvNih1aDEEM9Q3rclo_idFtMhpN_ZoGftgw5hyeVO96sxQ_NuH87z6dfXl58XX-vrbYnkxv65bUHisiZVUcUYocGaFJ7a1nuIGJFBqHEw94R0IAdxZJ6FRHRXEGug4EMEazs6r5ZHrklnr2xw2Jt_rZII-XKS80iaPoR28JkqBIgJAth04QmyDu8Z5KbAXoKScWJ-PrNut3XjX-jhmMzyDPu_E0OtVutOSgZCCTYCPD4Ccfm99GfUmlEnOYKJP26IpUMkpa6Saoh_-i67TNk9L36eI4sAx0CmFj6k2p1Ky7x4fQ7Dey9cH-XovXx_kTyPvn37iceCfbfYXV3-pTw</recordid><startdate>20200702</startdate><enddate>20200702</enddate><creator>Sami, Armin</creator><creator>Selzer, Michael E</creator><creator>Li, Shuxin</creator><general>Frontiers Research Foundation</general><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88I</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200702</creationdate><title>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</title><author>Sami, Armin ; Selzer, Michael E ; Li, Shuxin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antigens</topic><topic>axon regeneration</topic><topic>Cellular Neuroscience</topic><topic>Chondroitin sulfate</topic><topic>CSPG receptor</topic><topic>Heparan sulfate</topic><topic>Injuries</topic><topic>intracellular signaling</topic><topic>Intracellular signalling</topic><topic>Kinases</topic><topic>LAR</topic><topic>Mammals</topic><topic>Phosphatase</topic><topic>Proteins</topic><topic>Proteoglycans</topic><topic>PTPσ</topic><topic>Regeneration</topic><topic>scar inhibition</topic><topic>Signal transduction</topic><topic>Spinal cord</topic><topic>Spinal cord injuries</topic><topic>Traumatic brain injury</topic><topic>Tyrosine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sami, Armin</creatorcontrib><creatorcontrib>Selzer, Michael E</creatorcontrib><creatorcontrib>Li, Shuxin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in cellular neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sami, Armin</au><au>Selzer, Michael E</au><au>Li, Shuxin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors</atitle><jtitle>Frontiers in cellular neuroscience</jtitle><addtitle>Front Cell Neurosci</addtitle><date>2020-07-02</date><risdate>2020</risdate><volume>14</volume><spage>174</spage><epage>174</epage><pages>174-174</pages><issn>1662-5102</issn><eissn>1662-5102</eissn><abstract>Axon growth inhibitors generated by reactive glial scars play an important role in failure of axon regeneration after CNS injury in mature mammals. Among the inhibitory factors, chondroitin sulfate proteoglycans (CSPGs) are potent suppressors of axon regeneration and are important molecular targets for designing effective therapies for traumatic brain injury or spinal cord injury (SCI). CSPGs bind with high affinity to several transmembrane receptors, including two members of the leukocyte common antigen related (LAR) subfamily of receptor protein tyrosine phosphatases (RPTPs). Recent studies demonstrate that multiple intracellular signaling pathways downstream of these two RPTPs mediate the growth-inhibitory actions of CSPGs. A better understanding of these signaling pathways may facilitate development of new and effective therapies for CNS disorders characterized by axonal disconnections. This review will focus on recent advances in the downstream signaling pathways of scar-mediated inhibition and their potential as the molecular targets for CNS repair.</abstract><cop>Switzerland</cop><pub>Frontiers Research Foundation</pub><pmid>32714150</pmid><doi>10.3389/fncel.2020.00174</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1662-5102
ispartof Frontiers in cellular neuroscience, 2020-07, Vol.14, p.174-174
issn 1662-5102
1662-5102
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1994916447cf4d11b80f8de760e64977
source PubMed Central (Open Access); Publicly Available Content (ProQuest)
subjects Antigens
axon regeneration
Cellular Neuroscience
Chondroitin sulfate
CSPG receptor
Heparan sulfate
Injuries
intracellular signaling
Intracellular signalling
Kinases
LAR
Mammals
Phosphatase
Proteins
Proteoglycans
PTPσ
Regeneration
scar inhibition
Signal transduction
Spinal cord
Spinal cord injuries
Traumatic brain injury
Tyrosine
title Advances in the Signaling Pathways Downstream of Glial-Scar Axon Growth Inhibitors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T02%3A15%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20the%20Signaling%20Pathways%20Downstream%20of%20Glial-Scar%20Axon%20Growth%20Inhibitors&rft.jtitle=Frontiers%20in%20cellular%20neuroscience&rft.au=Sami,%20Armin&rft.date=2020-07-02&rft.volume=14&rft.spage=174&rft.epage=174&rft.pages=174-174&rft.issn=1662-5102&rft.eissn=1662-5102&rft_id=info:doi/10.3389/fncel.2020.00174&rft_dat=%3Cproquest_doaj_%3E2419545042%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c490t-1b7295312453b6e1bcbe20847422ad42956ed46645dbd7489f261ba4f54163853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2419545042&rft_id=info:pmid/32714150&rfr_iscdi=true